What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Antibiotics
Jacques F. Meis focuses on Microbiology, Aspergillus fumigatus, Aspergillosis, Posaconazole and Voriconazole.
Microbiology is a component of his Itraconazole, Amphotericin B, Azole, Fluconazole and Drug resistance studies.
His studies deal with areas such as Aspergillus, Fungi imperfecti, Genotype, Fungal protein and Chronic pulmonary aspergillosis as well as Aspergillus fumigatus.
In his study, which falls under the umbrella issue of Genotype, Genotyping is strongly linked to Typing.
He has researched Aspergillosis in several fields, including Intensive care medicine, Mycosis and Pathology.
The study incorporates disciplines such as Mucormycosis, Mucorales, Caspofungin and Fungicide in addition to Posaconazole.
His most cited work include:
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus (2079 citations)
- Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses (576 citations)
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Microbiology, Amphotericin B, Voriconazole, Aspergillus fumigatus and Aspergillosis.
His Microbiology study typically links adjacent topics like Genotype.
His study in Amphotericin B is interdisciplinary in nature, drawing from both Broth microdilution and Pharmacology.
His Aspergillus fumigatus research incorporates themes from Fungi imperfecti, Drug resistance and Aspergillus.
His Aspergillosis study combines topics in areas such as Fungemia, Mycosis, Internal medicine and Superinfection.
His Fluconazole course of study focuses on Candida auris and Outbreak.
He most often published in these fields:
- Microbiology (52.16%)
- Amphotericin B (17.25%)
- Voriconazole (17.39%)
What were the highlights of his more recent work (between 2017-2021)?
- Microbiology (52.16%)
- Candida auris (8.21%)
- Aspergillus fumigatus (16.69%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Microbiology, Candida auris, Aspergillus fumigatus, Voriconazole and Azole.
Much of his study explores Microbiology relationship to Genotype.
The various areas that Jacques F. Meis examines in his Candida auris study include Infection control, Corpus albicans, Intensive care, Outbreak and Internal medicine.
His work carried out in the field of Aspergillus fumigatus brings together such families of science as Bronchoalveolar lavage, Genotyping, Aspergillosis and Agar.
His Aspergillosis study which covers Aspergillus that intersects with Aspergillus flavus and Intensive care medicine.
His Azole research is multidisciplinary, incorporating perspectives in Gene and Drug resistance.
Between 2017 and 2021, his most popular works were:
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
- A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. (184 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Bacteria
His main research concerns Microbiology, Candida auris, Azole, Aspergillus fumigatus and Voriconazole.
His research combines Genotype and Microbiology.
His Candida auris research integrates issues from Epidemiology, Infection control, Outbreak, Public health and Virulence.
The Aspergillus fumigatus study combines topics in areas such as Fungicide, Resistance, Agar, Antifungal and Aspergillosis.
His Voriconazole research is multidisciplinary, relying on both Itraconazole and Susceptibility testing.
The various areas that Jacques F. Meis examines in his Amphotericin B study include Fusarium and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
